This invention relates to newly identified polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides, to their use in therapy and in identifying compounds which may be stimulators and/or inhibitors which are useful in therapy, and to production of such polypeptides and polynucleotides.

 
Web www.patentalert.com

< Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry

< Method for purifying enzymes from clostridium histolyticum using multi-stage chromatography

> Process for cooking/drying high-amylose starches

> Inhibitors of the interaction between P53 and MDM2

~ 00278